The LATAM Ledger: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The LATAM Ledger.

Press releases published on July 23, 2026

MacroGenics Provides Clinical Update on Ongoing Phase 1 Study for MGC026
Private Jets, Italian Robes, Signature Spritzes, And Zero Drama: Royalton Hotels & Resorts Introduces The Ultimate Luxury Escape
Jets Privados, Batas Italianas, Spritz De Autor Y Cero Drama: Royalton Hotels & Resorts Presenta La Experiencia De Lujo Más Exclusiva
NCA Launches New Learning Center to Support Child Nutrition Professionals
Inter.co Stadium Marks Next Chapter in Partnership with Orlando City SC & Orlando Pride
Antigua and Barbuda Tourism Authority USA Earns Accolades for Strengthening Travel Trade and Diaspora Engagement
OKYO Pharma Announces Purchase of Shares by Director
Red Cat and C3A Advance Black Widow™ Integration into OBERON-Enabled Fires Networks
Indivior to Report Second Quarter 2026 Financial Results and Host Webcast
InterPrivate Investment Partners V Announces the Separate Trading of Its Class A Ordinary Shares and Warrants, Commencing on or About July 27, 2026
Critical Metals Corp Advances to Final Round of Kenya Government Tender for the World-Class Mrima Hill Rare Earth and Niobium Project
Bitget Registers as a New Zealand Financial Services Provider
Greenland Mines Announces Limited-Duration Stockholder Rights Plan Intended to Protect Shareholder Value
Blue Gold Advances Producing Mine Acquisition Strategy to Drive Cash Flow
Commerce Secretary Lutnick, U.S. Senator Tim Scott and Governor Henry McMaster to Celebrate Historic 10% Increase in U.S. Aluminum Production
Ardelyx to Report Second Quarter 2026 Financial Results on August 6, 2026
New Book Challenges What Women Have Been Taught to Believe About Identity
Upcomers Launches 2.0, Expanding Into Futures With an AI Coach and a Redesigned Experience
Atsena Therapeutics Receives Orphan Designation from the European Medicines Agency (EMA) for ATSN-101 and ATSN-201
Inhibikase Therapeutics Announces FDA Orphan Drug Designation Granted to IKT-001 for the Treatment of PAH

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

The LATAM Ledger

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.